PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $33,914,620 | +1.1% | 831,037 | -4.3% | 2.56% | -5.1% |
Q4 2022 | $33,539,966 | -49.6% | 868,686 | -30.6% | 2.69% | -42.8% |
Q3 2022 | $66,612,000 | -21.8% | 1,252,342 | -14.3% | 4.71% | -0.5% |
Q2 2022 | $85,155,000 | -40.4% | 1,460,634 | -21.9% | 4.73% | -3.0% |
Q1 2022 | $142,798,000 | +12.8% | 1,871,040 | -11.0% | 4.88% | +45.3% |
Q4 2021 | $126,547,000 | +2.2% | 2,103,165 | -4.9% | 3.36% | +18.2% |
Q3 2021 | $123,828,000 | -3.6% | 2,211,210 | +4.4% | 2.84% | -0.7% |
Q2 2021 | $128,500,000 | -7.3% | 2,117,673 | +7.1% | 2.86% | -21.7% |
Q1 2021 | $138,631,000 | +17.4% | 1,977,897 | +0.3% | 3.65% | +0.9% |
Q4 2020 | $118,039,000 | +8.3% | 1,972,570 | +8.8% | 3.62% | -28.1% |
Q3 2020 | $108,990,000 | +35.7% | 1,812,877 | +18.4% | 5.04% | +1.3% |
Q2 2020 | $80,323,000 | +101.2% | 1,530,831 | +28.6% | 4.98% | +10.3% |
Q1 2020 | $39,919,000 | +2.8% | 1,190,537 | +38.9% | 4.51% | -9.5% |
Q4 2019 | $38,814,000 | +123.0% | 856,827 | +87.4% | 4.98% | +7.8% |
Q3 2019 | $17,408,000 | +5.4% | 457,250 | +20.5% | 4.62% | -11.4% |
Q2 2019 | $16,509,000 | +82.0% | 379,609 | +59.3% | 5.22% | +48.6% |
Q1 2019 | $9,071,000 | +75.5% | 238,327 | +98.3% | 3.51% | -9.4% |
Q4 2018 | $5,169,000 | – | 120,157 | – | 3.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |